
The FY2027 appropriations process gives Congress an immediate opportunity to protect medical cannabis patients from discrimination while addressing the gaps left by the Attorney General's order. Through funding directives, legislative provisions, and committee report language, Congress can require federal agencies to protect patients, update outdated policies, and establish the safeguards necessary for safe access and healthcare integration. These actions cannot replace comprehensive medical cannabis legislation, but they can help ensure that patients are not left behind while Congress develops a national framework.
For ASA's complete appropriations agenda, detailed requests across all seven subcommittees, and the latest congressional developments, visit our FY2027 Medical Cannabis Appropriations Hub. The hub will be updated as Congress considers FY2027 funding legislation and patient advocacy opportunities.
DOWNLOAD PROPOSED DOD APPROPS LANGUAGE | TAKE ACTION
WHY THE DOD SUBCOMMITTEE MUST ACT
The Department of Defense (DOD) must balance military readiness, operational safety, and discipline with service members' medical needs. Although the Attorney General's April 2026 order established a federal registration pathway for qualifying medical cannabis products, it did not change the Uniform Code of Military Justice (UCMJ) or existing military restrictions on cannabis and cannabinoid products. Service members remain subject to federal military policies regardless of whether medical cannabis is authorized under state law.
Under Article 112a of the UCMJ, wrongful possession, consumption, and other prohibited activities involving marijuana remain punishable offenses. Individual military branches also maintain restrictions on hemp-derived cannabinoids and cannabidiol (CBD), subject to applicable exceptions for authorized medications. These policies affect service members managing chronic pain, post-traumatic stress disorder (PTSD), traumatic brain injuries, and other medical conditions, particularly when they seek information about available therapies or prepare to transition into veterans' healthcare.

Each branch enforces this policy as follows:
- Army: AR600-85, section 4-2p
- Air Force: AFMAN 44-197, Paragraph 1.2.2.1
- Navy & Marines: ALNAV 057/19, Paragraph 3
- Coast Guard: COMDTINST M1000.10A, Chapter 5, Section D.1

Congress should direct DOD to review Department-wide and branch-specific cannabis and cannabinoid policies to determine which restrictions remain necessary for deployment, weapons-related duties, aviation, and other safety-sensitive assignments. The review should also identify appropriate procedures for medical disclosure, clinical consultation, disability evaluation, transition planning, and continuity of care. Military readiness requirements should remain intact while service members have clear, consistent opportunities to seek medical guidance without automatically treating a request for clinical advice as misconduct.
DEPARTMENT OF DEFENSE COMMITTEE REQUESTS |
Americans for Safe Access requests that Congress direct DOD to conduct a comprehensive review of policies governing cannabis, hemp-derived cannabinoids, CBD, and state-authorized medical cannabis. The review should distinguish restrictions necessary for military readiness and operational safety from policies that unnecessarily discourage clinical consultation, medical disclosure, or continuity-of-care planning.
DOD should identify administrative changes it can implement under existing authority, establish appropriate clinical-review procedures, and report to Congress on any statutory changes needed to address remaining gaps.
PROPOSED BILL LANGUAGE
SEC. __. DEPARTMENT OF DEFENSE MEDICAL CANNABIS POLICY REVIEW.
(a) Policy Review. Not later than 30 days after the date of enactment of this Act, the Secretary of Defense shall initiate a Department-wide and branch-specific review of policies governing cannabis, hemp-derived cannabinoids, cannabidiol products, and state-authorized medical cannabis.
(b) Scope of Review. The review shall identify restrictions necessary to protect military readiness, discipline, deployment requirements, weapons-related duties, aviation operations, and other safety-sensitive activities. The Secretary shall also evaluate existing policies and procedures governing medical disclosure, clinical consultation, disability evaluation, transition planning, and continuity of care for service members seeking medical information or treatment involving cannabis or cannabinoid therapeutics.
(c) Guidance and Reporting. Not later than 180 days after the date of enactment of this Act, the Secretary shall submit a report to the congressional defense committees identifying recommended administrative and statutory changes and shall issue guidance, consistent with applicable federal law and the Uniform Code of Military Justice, establishing appropriate procedures for medical disclosure and clinical review. Such guidance shall distinguish requests for medical consultation from evidence of prohibited conduct, preserve restrictions necessary for operational safety, and support continuity of care during the transition from military service to veteran healthcare.
DOWNLOAD PROPOSED DOD APPROPS LANGUAGE | TAKE ACTION
THE PATH FORWARD |
The priorities outlined here are part of Americans for Safe Access' coordinated FY2027 appropriations agenda across seven congressional subcommittees. Together, these requests seek to protect patients, remove discriminatory barriers, strengthen federal accountability, and establish the policies necessary to integrate medical cannabis into American healthcare.
Congress can take meaningful action through the appropriations process while laying the groundwork for comprehensive medical cannabis legislation in the 120th Congress. Patients should not have to choose between the medicine they rely on and their healthcare, housing, livelihoods, or fundamental rights. Explore ASA's complete FY2027 Medical Cannabis Appropriations Agenda to learn how these requests work together and follow the latest congressional developments.
References & SourcesDEA Marijuana Rescheduling Regulatory Actions Uniform Code of Military Justice, Article 92, 10 U.S.C. § 892: Failure to Obey Order or Regulation |
Share this page